Galmed Pharmaceuticals Ltd. (GLMD) Fundamentals

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.
SHARE INFORMATION
Market Cap$ 6,287,471
Shares Outstanding21,113,066
Float21,704,482
Percent Float102.8%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.32
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions32
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months99,698
Institutional Holdings Percent12.7%
Institutional Sold Previous 3 Months25,480
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned3,548,949
TRADING INFO
52 Week High$ 2.73
52 Week Low$ 0.29
52 Week High Change$ -88.28
21 Day Moving Average$ 0.3396
21 Day Extended Moving Average$ 0.334877
50 Day Moving Average$ 0.3584
50 Day Extended Moving Average$ 0.36851
200 Day Moving Average$ 0.756756
200 Day Extended Moving Average$ 0.828512
10 Day Average Volume25,398
20 Day Average Volume31,978
30 Day Average Volume29,687
50 Day Average Volume35,459
Alpha-0.034409
Beta1.5117
Standard Deviation0.227074
R20.124249
7 Day Price Change$ -0.0233
7 Day Percent Change-7.26%
21 Day Price Change$ -0.0412
21 Day Percent Change-12.15%
30 Day Price Change$ -0.1019
30 Day Percent Change-25.49%
Month to Date Price Change$ -0.0823
Month to Date Percent Change-21.65%
Quarter to Date Price Change$ -0.01328
Quarter to Date Percent Change-4.27%
180 Day Price Change$ -0.2125
180 Day Percent Change-41.64%
200 Day Price Change$ -0.3101
200 Day Percent Change-51.01%
Year to Date Price Change$ -1.52
Year to Date Percent Change-83.64%

Galmed Pharmaceuticals Ltd. (GLMD) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.50
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio4.10
Leverage Ratio1.20
Quick Ratio4.00
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-0.40
Enterprise Value$ -11,058,914
Price to Sales0.00
Price to Free Cash-0.40
PE High Last 5 Years-4.60
Price To Book0.50
Price To Cash Flow0.00
PE Low Last 5 Years-6.00
Price to Tangible Book0.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-77.67
Return on Equity-95.16
Return on Capital-84.33

Galmed Pharmaceuticals Ltd. (GLMD) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBrightman Almagor Zohar & Co.
CEOAllen Baharaff
Emplyoees24
Last AuditUQ
CIK0001595353
IndustryBiotechnology
SectorHealthcare
NAICS-
CONTACT INFO
Address16 Tiomkin Street
Tel Aviv, 6578317
Websitehttps://www.galmedpharma.com
Facsimile+972 36938447
Telephone+972 36938448
Emailinfo@galmedpharma.com


Your Recent History
NASDAQ
GLMD
Galmed Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.